Vanguard Capital Opportunity Inv
VHCOX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Vanguard Capital Opportunity Fund Investor Shares (VHCOX) is an actively managed open-end mutual fund that seeks long-term capital appreciation by investing primarily in U.S. stocks, with an emphasis on companies considered to have prospects for above-average earnings growth potential at attractive valuations; the fund employs a multi-manager system advised by PRIMECAP Management Company, focusing on growth-oriented equities across large-, mid-, and small-capitalization segments in a blend style, including holdings such as Eli Lilly and Co., Amgen Inc., Micron Technology Inc., Microsoft Corp., and NVIDIA Corp. The fund offers Investor Shares with a net expense ratio of 0.43%, a minimum initial investment of $3,000, and daily pricing, alongside Admiral Shares (VHCAX) for qualified investors requiring a $50,000 minimum; it maintains low portfolio turnover of approximately 6%, total net assets exceeding $23 billion, and a category allocation predominantly in U.S. stocks (around 83%), non-U.S. stocks (12%), and cash equivalents. Launched on August 14, 1995, and domiciled in the United States with administrative operations based at The Vanguard Group, Inc. in Malvern, Pennsylvania, the fund targets individual and institutional investors seeking growth equity exposure, primarily in the U.S. market with limited international holdings. In recent developments, the fund has remained closed to most new investors since 2004 to manage capacity and protect performance, unlike related PRIMECAP-advised Vanguard funds such as PRIMECAP Fund (VPMCX) and PRIMECAP Core Fund (VPCCX), which reopened without restriction in June 2024 following a capacity review. PRIMECAP Management Company, founded in 1983 and headquartered in Pasadena, California, continues its longstanding advisory partnership with Vanguard, emphasizing bottom-up fundamental research and a long-term investment horizon without notable acquisitions, funding rounds, or strategic shifts specific to VHCOX in the last 1-2 years. The portfolio features high-conviction positions in healthcare (e.g., Eli Lilly at 12%), technology, and industrials sectors, reflecting ongoing adherence to its growth-at-a-reasonable-price strategy amid a stable operational structure.